Drug therapy. Hydralazine.
D000974:Antibodies, Antinuclear / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000139:chemically induced; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002908:Chronic Disease; D004341:Drug Evaluation; D004357:Drug Synergism; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D011433:Propranolol / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects
D000974:Antibodies, Antinuclear; D006830:Hydralazine; D011433:Propranolol